Monopar Therapeutics MNPR
NASDAQ MNPR
$81.42 +1.42 (+1.77%)
As of: Sep 30, 2026 · 12:16 PM EDT

Monopar Therapeutics (MNPR) Total Non-Current Liabilities (2020)

Updated

Monopar Therapeutics (MNPR) posted Total Non-Current Liabilities of $54,628 for Q3 2020, down 27.2% from the prior quarter.

Analysis

Monopar Therapeutics (MNPR) Total Non-Current Liabilities (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Monopar Therapeutics 715.17 Mn 433.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 54,628.00
Jun 30, 2020 75,021.00
API Access

Monopar Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=MNPR&period=max&api_key=YOUR_API_KEY